Cogent Biosciences (COGT) Change in Cash (2017 - 2021)
Historic Change in Cash for Cogent Biosciences (COGT) over the last 5 years, with Q4 2021 value amounting to $16.8 million.
- Cogent Biosciences' Change in Cash fell 8510.6% to $16.8 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$22.5 million, marking a year-over-year decrease of 11099.11%. This contributed to the annual value of $214.3 million for FY2025, which is 37681.81% up from last year.
- Per Cogent Biosciences' latest filing, its Change in Cash stood at $16.8 million for Q4 2021, which was down 8510.6% from -$15.2 million recorded in Q3 2021.
- In the past 5 years, Cogent Biosciences' Change in Cash registered a high of $112.8 million during Q4 2020, and its lowest value of -$15.2 million during Q3 2021.
- Moreover, its 5-year median value for Change in Cash was -$2.5 million (2017), whereas its average is $8.9 million.
- As far as peak fluctuations go, Cogent Biosciences' Change in Cash tumbled by 49701.67% in 2019, and later skyrocketed by 143329.39% in 2020.
- Cogent Biosciences' Change in Cash (Quarter) stood at -$2.4 million in 2017, then surged by 371.28% to $6.4 million in 2018, then crashed by 232.67% to -$8.5 million in 2019, then surged by 1433.29% to $112.8 million in 2020, then crashed by 85.11% to $16.8 million in 2021.
- Its Change in Cash stands at $16.8 million for Q4 2021, versus -$15.2 million for Q3 2021 and -$12.6 million for Q2 2021.